Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions

Catheterization and Cardiovascular Diagnosis

Volumn 44, Issue 3, 1998, Pages 257-264

  Watkins, Matthew W ^a   Luetmer, Paul A ^b   Schneider, David J ^a   Witmer, William T ^c   Vaitkus, Paul T ^d   Sobel, Burton E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b Cardiovasc Assoc of N Wisconsin   (United States)

^c Northeast Cardiology Associates   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Coronary sinus; Fibrinopeptide A; Heparin; thromboglobulin

Indexed keywords

BETA THROMBOGLOBULIN; BIOCHEMICAL MARKER; FIBRINOPEPTIDE A; HEPARIN;

ADULT; AGED; ARTICLE; ATHERECTOMY; BLOOD SAMPLING; CATHETERIZATION; CLINICAL ARTICLE; CORONARY ARTERY SURGERY; CORONARY SINUS; DRUG WITHDRAWAL; FEMALE; FEMORAL VEIN; HEART INFARCTION; HEPARINIZATION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REBOUND;

EID: 0031804601     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199807)44:3<257::AID-CCD2>3.0.CO;2-4     Document Type: Article

References (21)

1. Rath B, Bennett DH: Monitoring the effect of heparin by measurements of activated clotting time during and after percutaneous transluminal coronary angioplasty. Br Heart J 63:18-21, 1990.
2. Ferguson JJ, Dougherty KG, Gaos CM, Bush HS, March KC, Leachman DR: Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 23:1061-1065, 1994.
3. Detre KM, Homes DR, Holubkov R, Cowley MJ, Boursassa MG, Faxon DP, Dorros GR, Bentivoglio LG, Kent KM, Myler RK: Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 82:739-750, 1990.
4. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ: Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile. J Am Coll Cardiol 19:1926-1935, 1992.
5. Laskey MA, Deutsch E, Hirshfeld JW, Kussmaul WG, Barnathan E, Laskey WK: Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombosis. Am J Cardiol 65:179-182, 1990.
6. Oltrona L, Eisenberg PR, Lasala JM, Sewall DJ, Shelton ME, Winters KJ: Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions. Circulation 94:2064-2071, 1996.
7. Vaitkus PT, Watkins MW, Witmer WT, Tracy RP, Sobel BE: Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty. Coronary Artery Dis 6:587-592, 1995.
8. Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C, Berrios E, Harrington RA, Ohman EM, Califf RM: Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 91:1929-1935, 1995.
9. Marmur JD, Merlini PA, Sharma SK, Khaghan N, Torre SR, Israel DH, Ardissino D, Ambrose JA: Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol 24:1484-1491, 1994.
10. Scharf RE, Tomer A, Marzec UM, Teirstein PS, Ruggeri ZM, Harker LA: Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Arterioscler Thromb 12:1475-1487, 1992.
11. Shammas NW, Cunningham MJ, Pomerantz RM, Francis CW: Markers of hemostatic activation in affected coronary arteries during angioplasty. Thromb Haemost 72:672-675, 1994.
12. Brezinski DA, Nesto RW, Sherhan CN: Angioplasty triggers intracoronary leukotrienes and lipoxin A: Impact of aspirin therapy. Circulation 86:56-63, 1992.
13. George BS, Voorhees WD, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE, King SB, Holmes DR, Topol EJ, Kereiakes DJ, Hartzler GO: Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiopgraphic outcomes. J Am Coll Cardiol 22:135-143, 1993.
14. Gold HK, Torres F, Garabedian H, Werner W, Jang IK, Khan A, Hagstrom J, Yasuda T, Leinbach R, Newell J, Bovill EG, Stump DC, Collen D: Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol 21:1039-1047, 1993.
15. Theroux P, Waters D, Lam J, Juneau M, Meccans J: Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 327:141-145, 1992.
16. Mombelli G, Hof VI, Haeberli A, Straub PW: Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction. Circulation 69:784-689, 1984.
17. Willerson JT, Casscella W: Thrombin inhibitors in unstable angina: Rebound or continuation of angina after argatroban withdrawal? J Am Coll Cardiol 21:1048-1051, 1993.
18. Eisenberg PR, Sherman LA, Schectman K, Perez J, Sobel BE, Jaffe AS: Fibrinopeptide A : A marker of acute coronary thrombosis. Circulation 71:912-918, 1985.
19. Swords NA, Tracy PB, Mann KG: Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets. Arterioscler Thromb 13:1613-1622, 1993.
20. Meinrad G, Neumann FJ, Ilka O, Schiessler A, Sch[00f6]mig A: Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 93:229-237, 1996.
21. Inoue T, Hoshi K, Fujito S, Sakai Y, Morooska S, Sohma R: Early detection of platelet activation after coronary angioplasty. Coronary Artery Dis 7:529-534, 1996.